Lunai Bioworks (LNAI) Net Equity Issued and Repurchased (2011 - 2022)
Lunai Bioworks (LNAI) posted quarterly Net Equity Issued and Repurchased of $451700.0 for Q1 2022, down 97.01% quarter-over-quarter from $15.1 million in Q1 2018.
Lunai Bioworks (LNAI) Net Equity Issued and Repurchased (2011 - 2022) Analysis & Trends
Lunai Bioworks' Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $451700.0 for Q1 2022.
- In Q1 2022, Net Equity Issued and Repurchased changed N/A year-over-year to $451700.0; the TTM figure through Mar 2022 stood at $18.8 million (changed N/A YoY), while the FY2018 annual figure was $16.7 million, up 376.15% from the prior year.
- Net Equity Issued and Repurchased for Q1 2022 stood at $451700.0, down from $15.1 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $15.1 million in Q1 2018, with the low at $451700.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 451,700.00 |
| Mar 31, 2022 | 451,700.00 |
| Mar 31, 2018 | 15.11 Mn |
| Mar 31, 2018 | 15.11 Mn |
| Dec 31, 2017 | 3.20 Mn |
| Dec 31, 2017 | 3.20 Mn |
| Sep 30, 2017 | -1.60 Mn |
| Sep 30, 2017 | -1.60 Mn |
| Mar 31, 2015 | 7.38 Mn |
| Mar 31, 2015 | 7.38 Mn |
| Sep 30, 2014 | 636,140.00 |
| Sep 30, 2014 | 636,140.00 |
| Dec 31, 2011 | 25,000.00 |
| Dec 31, 2011 | 25,000.00 |
| Sep 30, 2011 | 25,000.00 |
| Sep 30, 2011 | 25,000.00 |